Keyphrases
Wnt Signaling
47%
Wnt Signaling Pathway
44%
Colon Cancer
41%
Care Coordination
37%
Chediak-Higashi Syndrome
35%
Levamisole
34%
Catenin
26%
Peripheral Blood Mononuclear Cells
25%
Cancer Patients
24%
In Cancer
24%
Wnt Ligands
23%
Clinical Trials
23%
5-fluorouracil (5-FU)
23%
LAMP2
22%
Metastatic Colorectal Cancer (mCRC)
22%
Chemotherapy
21%
Health Systems
19%
Patient Satisfaction
19%
Gemcitabine
18%
Hawaii
18%
T Cells
18%
Cancer Care Coordination
18%
LEF1
17%
Resveratrol
17%
Wnt Antagonists
17%
Colon
17%
Cancer Care
17%
Signaling Pathway
17%
Tumor
17%
Healthcare Professionals
17%
Oncohematology
16%
Tumor Microenvironment
16%
Clinical Research
15%
New York City
15%
Inflammatory Bowel Disease
15%
Southwest Oncology Group
15%
T Cell Receptor
14%
Colon Adenocarcinoma
13%
Rural Patients
13%
Oncologists
13%
United States
13%
Interleukin-2
12%
Wnt Genes
12%
Genistein
12%
Patient Perception
12%
Interferon-α (IFN-α)
12%
Lipids
12%
Wnt2
12%
Surface Expression
12%
Colonic mucosa
11%
Medicine and Dentistry
Malignant Neoplasm
100%
Oncology
54%
Wnt Signaling
43%
Care Coordination
37%
Colon Carcinoma
30%
Clinical Trial
29%
Cancer
25%
Hematology
21%
Diseases
20%
Cancer Therapy
20%
Clinical Research
20%
Breast Cancer
18%
Carcinogenesis
15%
Levamisole
15%
Cholangiocarcinoma
15%
Gemcitabine
13%
Granulocyte
12%
Oncologist
12%
Frizzled Protein
12%
Tumor Microenvironment
11%
In Vitro
11%
Tumor
11%
Health Care Cost
11%
Health Care Personnel
10%
Metastatic Carcinoma
10%
Patient Satisfaction
10%
Mammography
10%
Lymphoid Enhancer Factor 1
10%
Pancreas Cancer
10%
Cell Invasion
10%
Inflammatory Bowel Disease
10%
Overall Survival
9%
Chediak Higashi Syndrome
9%
Low Drug Dose
9%
Radiation Therapy
9%
Cancer Prevention
9%
Peripheral Blood Mononuclear Cell
8%
Receptor
8%
Lymphocyte
8%
Neoplasm
8%
Clinician
8%
Catenin
8%
Colon Mucosa
8%
Platelet
7%
Gastroesophageal Junction
7%
Interleukin 2
7%
Prescription Medication
7%
Mesenchymal-Epithelial Transition
7%
Resveratrol
7%
Melanoma
7%